Page last updated: 2024-11-02

pentoxifylline and Pulmonary Disease, Chronic Obstructive

pentoxifylline has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zheng, XF1
Chen, DD1
Zhu, XL1
Le Grange, JM1
Zhou, LQ1
Zhang, JN1

Other Studies

1 other study available for pentoxifylline and Pulmonary Disease, Chronic Obstructive

ArticleYear
Impacts of anti-inflammatory phosphodiesterase inhibitors on a murine model of chronic pulmonary inflammation.
    Pharmacology research & perspectives, 2021, Volume: 9, Issue:4

    Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Cyclopropanes; Disease Models, Animal

2021